ISSN:
0732-183X
eISSN:
1527-7755
Disciplines
(Field of Science):
- biomedical engineering (Engineering and Technology)
- medical biology (Medical and Health Sciences )
- pharmacology and pharmacy (Medical and Health Sciences )
- medical sciences (Medical and Health Sciences )
- health sciences (Medical and Health Sciences )
- biotechnology (Natural sciences)
(Field of Science)
Ministry points: Help
Year | Points | List |
---|---|---|
Year 2024 | 200 | Ministry scored journals list 2024 |
Year | Points | List |
---|---|---|
2024 | 200 | Ministry scored journals list 2024 |
2023 | 200 | Ministry Scored Journals List |
2022 | 200 | Ministry Scored Journals List 2019-2022 |
2021 | 200 | Ministry Scored Journals List 2019-2022 |
2020 | 200 | Ministry Scored Journals List 2019-2022 |
2019 | 200 | Ministry Scored Journals List 2019-2022 |
2018 | 50 | A |
2017 | 50 | A |
2016 | 45 | A |
2015 | 45 | A |
2014 | 50 | A |
2013 | 45 | A |
2012 | 50 | A |
2011 | 50 | A |
2010 | 32 | A |
Model:
Hybrid
Points CiteScore:
Year | Points |
---|---|
Year 2022 | 39.6 |
Year | Points |
---|---|
2022 | 39.6 |
2021 | 40.9 |
2020 | 37 |
2019 | 35.4 |
2018 | 35.1 |
2017 | 31.4 |
2016 | 29.9 |
2015 | 28.6 |
2014 | 26.3 |
2013 | 27.8 |
2012 | 28.9 |
2011 | 26.7 |
Impact Factor:
Log in to see the Impact Factor.
Sherpa Romeo:
Papers published in journal
Filters
total: 5
Catalog Journals
-
Why they want to be treated in clinical trial -fundamental reasons of patient's decision
Publication -
Complementary and alternative medicine (CAM) use among patients with cancer undergoing palliative care: A pilot study of a single institution in Poland.
Publication -
Ibrutinib as Treatment for Patients With Relapsed/Refractory Follicular Lymphoma: Results From the Open-Label, Multicenter, Phase II DAWN Study
Publication -
Venetoclax for Patients With Chronic Lymphocytic Leukemia With 17p Deletion: Results From the Full Population of a Phase II Pivotal Trial
Publication -
Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
Publication
seen 424 times